Allergan Current Ratio 2006-2019 | AGN

Current and historical current ratio for Allergan (AGN) from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Allergan current ratio for the three months ending June 30, 2019 was 1.03.
Allergan Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-06-30 $8.57B $8.30B 1.03
2019-03-31 $6.29B $8.85B 0.71
2018-12-31 $6.48B $5.73B 1.13
2018-09-30 $5.74B $6.23B 0.92
2018-06-30 $6.10B $6.13B 1.00
2018-03-31 $6.39B $5.82B 1.10
2017-12-31 $11.38B $9.85B 1.16
2017-09-30 $10.11B $8.56B 1.18
2017-06-30 $10.43B $8.64B 1.21
2017-03-31 $13.70B $10.39B 1.32
2016-12-31 $17.86B $7.88B 2.27
2016-09-30 $31.72B $8.03B 3.95
2016-06-30 $8.76B $8.87B 0.99
2016-03-31 $10.09B $10.20B 0.99
2015-12-31 $8.58B $8.29B 1.04
2015-09-30 $16.66B $8.13B 2.05
2015-06-30 $10.49B $7.65B 1.37
2015-03-31 $11.02B $7.66B 1.44
2014-12-31 $7.11B $5.25B 1.36
2014-09-30 $6.25B $4.48B 1.40
2014-06-30 $8.27B $4.18B 1.98
2014-03-31 $4.54B $3.00B 1.51
2013-12-31 $4.44B $3.30B 1.35
2013-09-30 $4.07B $2.81B 1.45
2013-06-30 $3.92B $2.39B 1.64
2013-03-31 $3.84B $2.94B 1.31
2012-12-31 $3.84B $2.75B 1.40
2012-09-30 $2.44B $1.56B 1.57
2012-06-30 $2.32B $1.53B 1.52
2012-03-31 $2.41B $1.58B 1.53
2011-12-31 $2.57B $1.84B 1.40
2011-09-30 $1.84B $1.02B 1.81
2011-06-30 $2.01B $1.37B 1.47
2011-03-31 $1.94B $0.86B 2.26
2010-12-31 $1.79B $0.81B 2.21
2010-09-30 $1.76B $0.75B 2.34
2010-06-30 $1.76B $0.75B 2.33
2010-03-31 $1.77B $0.88B 2.01
2009-12-31 $1.77B $1.05B 1.69
2009-09-30 $1.89B $0.44B 4.29
2009-06-30 $1.69B $1.19B 1.42
2009-03-31 $1.56B $1.14B 1.37
2008-12-31 $1.46B $0.48B 3.03
2008-09-30 $1.32B $0.40B 3.32
2008-06-30 $1.25B $0.43B 2.93
2008-03-31 $1.16B $0.44B 2.67
2007-12-31 $1.17B $0.45B 2.64
2007-09-30 $1.12B $0.40B 2.85
2007-06-30 $1.10B $0.46B 2.38
2007-03-31 $1.10B $0.45B 2.44
2006-12-31 $1.26B $0.69B 1.83
2006-09-30 $1.62B $0.35B 4.64
2006-06-30 $1.57B $0.38B 4.13
2006-03-31 $1.43B $0.31B 4.66
2005-12-31 $1.35B $0.25B 5.51
2005-09-30 $1.31B $0.25B 5.31
2005-06-30 $1.32B $0.24B 5.50
2005-03-31 $1.37B $0.24B 5.69
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $56.597B $15.787B
Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan plc, formerly known as Actavis plc, is headquartered in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Mylan (MYL) United States $9.740B 4.29
Teva Pharmaceutical Industries (TEVA) Israel $8.484B 3.33
Bausch Health Cos (BHC) Canada $8.023B 5.35
Dr Reddy's Laboratories (RDY) India $6.282B 21.18
ASPEN PHARMACR (APNHY) South Africa $3.087B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.395B 13.64
Amphastar Pharmaceuticals (AMPH) United States $0.969B 47.72
Akorn (AKRX) United States $0.592B 0.00
Homology Medicines (FIXX) United States $0.589B 0.00
Voyager Therapeutics (VYGR) United States $0.569B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.429B 0.00
Assembly Biosciences (ASMB) United States $0.399B 0.00
CymaBay Therapeutics (CBAY) United States $0.315B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.214B 0.29
Zynerba Pharmaceuticals (ZYNE) United States $0.194B 0.00
Sol-Gel Technologies (SLGL) Israel $0.154B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.111B 0.00
Teligent (TLGT) United States $0.038B 0.00